Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Aquis AQSE - Delayed Quote GBp

TruSpine Technologies Plc (TSP.AQ)

0.7475
+0.1175
+(18.65%)
At close: April 17 at 8:30:09 AM GMT+1
Loading Chart for TSP.AQ
  • Previous Close 0.6300
  • Open 0.7475
  • Bid --
  • Ask --
  • Day's Range 0.7475 - 0.7475
  • 52 Week Range 0.0055 - 0.7475
  • Volume 6,688
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

TruSpine Technologies Plc, a medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States. Its products include Cervi-LOK, a screw free spinal stabilization system for cervical and upper thoracic spine; Faci-LOK, a system for lumbar and lower thoracic vertebra; and GRASP Laminoplasty system, a treatment for decompression of the spinal cord. TruSpine Technologies Plc was incorporated in 2014 and is based in London, the United Kingdom.

truspinetech.com

5

Full Time Employees

March 29

Fiscal Year Ends

Recent News: TSP.AQ

View More

Performance Overview: TSP.AQ

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

TSP.AQ
7,019.05%
MSCI WORLD (^990100-USD-STRD)
7.68%

1-Year Return

TSP.AQ
4,571.88%
MSCI WORLD (^990100-USD-STRD)
4.29%

3-Year Return

TSP.AQ
1,172.34%
MSCI WORLD (^990100-USD-STRD)
18.75%

5-Year Return

TSP.AQ
113.57%
MSCI WORLD (^990100-USD-STRD)
73.90%

Compare To: TSP.AQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TSP.AQ

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -12.59%

  • Return on Equity (ttm)

    -25.33%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -607.3k

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    50.82k

  • Total Debt/Equity (mrq)

    9.86%

  • Levered Free Cash Flow (ttm)

    -141.25k

Research Analysis: TSP.AQ

View More

Company Insights: TSP.AQ

Research Reports: TSP.AQ

View More